TIPS-3, PHRI’s study on the polypill, will be presented at a late-breaking science session at the American Heart Association’s (virtual) Scientific Sessions on November 13, 2020.

Part of the Late Breaking Science Session: Bending the Curve for CV Disease – Precision or PolyPill?, the TIPS-3 presentations will include:

  • “A Polypill for Primary Prevention of Cardiovascular Disease in Intermediate Risk People: Results of The International Polycap Study (TIPS)-3” by Prem Pais, St John’s Research Institute, Bangalore, India.
  • “Aspirin Alone and in Combination with a Polypill in Cardiovascular Disease Primary Prevention: Results from The International Polycap Study (TIPS)-3” by Salim Yusuf, PHRI Executive Director.

Also on November 13, 2020, Dr. Yusuf will participate in a live “Meet the Trialists” session, discussing the TIPS-3 study.

Registration is now open for the AHA 2020 Scientific Sessions: A Virtual Experience, happening November 13 – 17. Follow #AHA20 on Twitter, including @AHAscience and @AHAmeetings.

TIPS-3 global study team

Back To Top